Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of VLA15 Lyme Disease Vaccine in Healthy Children
NCT05634811Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2022
- Primary completion
- Jul 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of VLA15 in Lyme disease, sponsored by Pfizer. Started Dec 2022; status: completed.
02
Drugs
VLA15
03
Conditions
Lyme disease
Beyond the preview
Go deeper on NCT05634811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05634811.